Mark G. Bures - Concepedia

Author

Mark G. Bures

Also Known As

Bures, M., Bures, Mark G., M G Bures, M. Bures, M. G. BURES, M. G. Bures, M.G. Bures, Mark Bures, Mark G Bures, Mark G. Bures

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Abbott Fund Abbott (United States)Abbott (United Kingdom)Purdue University West Lafayette

About

Mark G. Bures is an author at Eli Lilly (United States) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.5K
2	Natural Sciences	11	11	782
3	Biochemistry	10	10	1K
4	Engineering	3	3	56
5	Allergy	1	1	56

Mark G. Bures

Publications

Citations

H-Index

Page 1

	Year	Citations
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists Yvonne C. Martin, Mark G. Bures, Elizabeth A. Danaher, Journal of Computer-Aided Molecular Design Medicinal ChemistryFast New ApproachPsychiatryFunctional SelectivityMedicine	1993	404
Privileged Molecules for Protein Binding Identified from NMR-Based Screening Philip J. Hajduk, Mark G. Bures, Jens Praestgaard, Journal of Medicinal Chemistry Targeted LibraryProtein TargetsDrug TargetBiochemistryMedicine	2000	346
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors David M. Thal, Bingfa Sun, Dan Feng, Nature BiochemistryG Protein-coupled ReceptorMedicineNeurotransmitterReceptor (Biochemistry)	2016	341
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x <sub>L</sub> from NMR and Parallel Synthesis Andrew M. Petros, Jürgen Dinges, David J. Augeri, Journal of Medicinal Chemistry	2005	291
Mechanism of differential activities of ofloxacin enantiomers Ian Morrissey, Kazuki Hoshino, Katsumasa Sato, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceBioorganic ChemistryAntibiotic AdjuvantAntibacterial ActivityChemical Biology	1996	95
Synthesis and Metabotropic Glutamate Receptor Activity of S-Oxidized Variants of (−)-4-Amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: Identification of Potent, Selective, and Orally Bioavailable Agonists for mGlu2/3 Receptors James A. Monn, Steven M. Massey, Matthew J. Valli, Journal of Medicinal Chemistry S-oxidized VariantsPharmacotherapyChemical BiologyTyrosine Residue Y236Molecular Pharmacology	2006	65
Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1<i>S</i>,2<i>S</i>,5<i>R</i>,6<i>S</i>-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: Identification of a Potent, Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures James A. Monn, Lourdes Prieto, Lorena Taboada, Journal of Medicinal Chemistry Pharmacological CharacterizationPharmacotherapyExperimental PharmacologyCompound 2C4-disubstituted Analogs	2015	59
Synthesis and Pharmacological Characterization of <i>C</i>4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1<i>R</i>,2<i>S</i>,4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-Amino-4-(1<i>H</i>-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu<sub>2</sub> Receptor Agonist James A. Monn, Lourdes Prieto, Lorena Taboada, Journal of Medicinal Chemistry Pharmacological CharacterizationImmunologyPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2015	56
Methyl Substitution of 2-Aminobicyclo[3.1.0]hexane 2,6-Dicarboxylate (LY354740) Determines Functional Activity at Metabotropic Glutamate Receptors: Identification of a Subtype Selective mGlu2 Receptor Agonist Carmen Domínguez, Lourdes Prieto, Matthew J. Valli, Journal of Medicinal Chemistry Mglu2/3 Receptor AntagonistMethyl SubstitutionMetabotropic Glutamate ReceptorsMolecular PhysiologyDetermines Functional Activity	2005	53
Ligand binding to domain-3 of human serum albumin: a chemometric analysis Philip J. Hajduk, Renaldo Mendoza, Andrew M. Petros, Journal of Computer-Aided Molecular Design	2003	49

Page 1